Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,717 | 93 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,197 | 77 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $262.67 | 2 | $0 (2024) |
| PFIZER INC. | $50.31 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $49.64 | 3 | $0 (2024) |
| Grifols USA, LLC | $42.55 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $26.81 | 1 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $23.67 | 1 | $0 (2022) |
| GENZYME CORPORATION | $22.07 | 1 | $0 (2023) |
| Melinta Therapeutics, Inc. | $16.94 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $13.61 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $590.90 | 35 | GlaxoSmithKline, LLC. ($389.43) |
| 2023 | $559.56 | 33 | GlaxoSmithKline, LLC. ($509.51) |
| 2022 | $410.70 | 21 | GlaxoSmithKline, LLC. ($297.87) |
| 2021 | $12.69 | 1 | Novartis Pharmaceuticals Corporation ($12.69) |
| 2020 | $112.72 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($112.72) |
| 2019 | $13.61 | 1 | Janssen Pharmaceuticals, Inc ($13.61) |
| 2018 | $16.94 | 1 | Melinta Therapeutics, Inc. ($16.94) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $149.95 | General |
| Category: Cardio-pulmonary | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Pulmonology | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 424 | 1,092 | $459,455 | $123,449 |
| 2022 | 6 | 255 | 492 | $75,912 | $35,893 |
| 2021 | 6 | 319 | 628 | $72,225 | $46,268 |
| 2020 | 6 | 266 | 529 | $63,252 | $40,943 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 103 | 452 | $262,160 | $68,267 | 26.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 328 | $71,110 | $21,187 | 29.8% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 47 | 111 | $46,065 | $13,825 | 30.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 54 | $24,360 | $5,711 | 23.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 36 | $22,140 | $5,151 | 23.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 60 | 63 | $13,960 | $4,182 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 23 | $9,315 | $2,102 | 22.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 11 | 12 | $6,120 | $1,781 | 29.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 13 | $4,225 | $1,242 | 29.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 287 | $30,448 | $16,276 | 53.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 72 | $13,342 | $8,024 | 60.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 66 | 70 | $7,174 | $4,152 | 57.9% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 21 | 21 | $12,600 | $3,313 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 27 | $6,470 | $2,553 | 39.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 14 | 15 | $5,878 | $1,575 | 26.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 118 | 409 | $38,213 | $24,639 | 64.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 62 | 65 | $11,614 | $7,324 | 63.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $7,637 | $4,877 | 63.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 74 | 80 | $7,592 | $4,816 | 63.4% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 24 | 28 | $4,566 | $2,999 | 65.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 17 | $2,604 | $1,613 | 61.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 88 | 327 | $30,862 | $20,067 | 65.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 54 | 59 | $15,483 | $10,013 | 64.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 63 | 67 | $6,409 | $4,137 | 64.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 29 | 31 | $5,494 | $3,570 | 65.0% |
About Dr. Atif Qadeer, MD
Dr. Atif Qadeer, MD is a Hospitalist healthcare provider based in Montclair, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730160201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atif Qadeer, MD has received a total of $1,717 in payments from pharmaceutical and medical device companies, with $590.90 received in 2024. These payments were reported across 93 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,717).
As a Medicare-enrolled provider, Qadeer has provided services to 1,264 Medicare beneficiaries, totaling 2,741 services with total Medicare billing of $246,552. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Montclair, CA
- Active Since 11/10/2005
- Last Updated 07/13/2022
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1730160201
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,168
- Adempas (Drug) $262.67
- ELIQUIS (Drug) $50.31
- Prolastin-C Liquid (Biological) $42.55
- LEQVIO (Drug) $36.95
- NURTEC ODT (Drug) $26.81
- GVOKE PFS (Drug) $23.67
- DUPIXENT (Biological) $22.07
- Baxdela (Drug) $16.94
- NUCALA (Biological) $15.23
- AREXVY (Drug) $13.90
- XARELTO (Drug) $13.61
- ENTRESTO (Drug) $12.69
- TEZSPIRE (Biological) $12.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Montclair
Ali Salem, M.d, M.D
Hospitalist — Payments: $4,033
Andres Gonzalez, M.d, M.D
Hospitalist — Payments: $1,562
Hammad Shaikh, M.d, M.D
Hospitalist — Payments: $1,342
Yeyong Shin, Do, DO
Hospitalist — Payments: $672.95
Dr. Nicole Sims, D.o, D.O
Hospitalist — Payments: $190.12
Mohammed Al-Khayyat, M.d, M.D
Hospitalist — Payments: $102.31